Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors? - Wikidata - awgldk - TriplyDB

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

http://www.wikidata.org/entity/Q37077360

about

Multiple roles for nicotine in Parkinson's disease Opioid system functional regulation in neurological disease management.Targeting nicotinic receptors for Parkinson's disease therapy.

P2860

Q22252514-C492258A-97D2-4CAF-8C38-165CE3079854 Q37782045-A7385F15-5CDB-41FF-AEFE-127629351AC9 Q37916643-30739733-CD80-49BB-BCC3-2D57817F2E18

P2860

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

http://www.wikidata.org/entity/Q37077360

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@en

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@nl

type

label

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@en

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@nl

prefLabel

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@en

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@nl

P1433

Q37077360-73EF73C5-E0B1-4BD0-974D-A8B91FBF996B

P1476

Q37077360-2A9AC55A-C8BB-470E-9832-C092C94BF7CD

P2093

Q37077360-9871A0A5-9B6D-4137-8A5C-5F8F1169632C

Q37077360-BFD76E6C-B41B-4317-8EB0-729FC00D3E64

P2860

Q37077360-1F481657-019D-4356-AB34-18FEE8BF2731

Q37077360-448D684F-3558-4CA5-8494-D0D55E0463A3

Q37077360-623C117D-D6E9-40E9-B5DA-DD87DDD0144B

Q37077360-A8E938CE-B0E1-44F6-953D-986FAFA389DE

Q37077360-ABAFBA3B-937E-43A5-AD4A-B833C04B584E

Q37077360-ACE2C9B9-CEAE-441B-8BA4-EE2ECE690241

Q37077360-AF4D235F-7C05-4F32-A9D7-60598C7CDEAB

Q37077360-BCE8FD3B-0074-405D-950A-98CF16A52084

Q37077360-C8327BD4-CDD8-458A-972B-2D4B274D992A

Q37077360-CEDF4EFE-C835-412A-B767-DE7583CEB122

P2888

Q37077360-3A80DA34-1357-450D-855D-C8BB4A305369

P304

Q37077360-C780B0C1-4AF8-4D1C-8F4D-A0684AD51F50

P31

Q37077360-271FCD28-B323-4E1D-A323-74E77BFB84F2

P356

Q37077360-716AEA18-9D23-463A-8906-B057476C0283

P433

Q37077360-EC0C7441-2CCC-4D0B-B7E3-A6BD68778435

P478

Q37077360-3A7DEE60-B71D-4F3C-8246-F4B55800AEA6

P50

Q37077360-23317FB4-69CE-4E13-B3DC-702429BF79BF

Q37077360-F5334706-001C-4194-9EAE-64AE0E1542C7

P577

Q37077360-5FBBEADC-A53D-4086-BE4D-589318B185E5

P5875

Q37077360-7648044B-8A73-4825-9E80-14ABE54EA6FD

P698

Q37077360-8615A653-4603-4F39-B3E0-07529B219BDE

P921

Q37077360-0dd4361e-ad30-47de-871d-a1a813971ce7

Q37077360-51BC8B52-4FDC-4BEA-BBAC-079F7D588BBF

Q37077360-D8B68ABD-BF4E-4AAB-8C2D-56F758B074C7

P356

S00702-007-0852-Z

P1433

Journal of Neural Transmission

P1476

Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors?

@en

P2093

G Linazasoro

http://www.w3.org/2001/XMLSchema#string

N Van Blercom

http://www.w3.org/2001/XMLSchema#string

P2860

Partial dopamine agonist therapy of levodopa-induced dyskinesias

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models.

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease.

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease.

Levodopa-induced dyskinesias are improved by fluoxetine.

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease.

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.

Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study.

P2888

s00702-007-0852-z

P304

431-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-007-0852-Z

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Jose Angel Ruiz-Ortega

P577

2008-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5601271

http://www.w3.org/2001/XMLSchema#string

P698

18250954

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease